Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index



Status:Completed
Conditions:Healthy Studies, Psoriasis, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery, Other
Healthy:No
Age Range:5 - 17
Updated:4/13/2015
Start Date:May 2009
End Date:July 2015
Contact:Gil Abramovici, MD
Email:gabramovici@luriechildrens.org
Phone:312-227-6484

Use our guide to learn which trials are right for you!

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis

The object of this research study is to examine these associations in children as very
little is known about psoriasis and cardiovascular risk factors in the pediatric population.

Several environmental factors and comorbid conditions have been found to be associated with
psoriasis in adults, including obesity, depression, smoking, and other cardiovascular risk
factors such as high blood pressure. The object of this research study is to examine these
associations in children as very little is known about psoriasis and cardiovascular risk
factors in the pediatric population.

This is a multi-center study with a planned total enrollment of about 200 subjects ages 2-17
years old with psoriasis and 100 aged-match controls. Patient and family history will be
recorded. All subjects will undergo standard height, weight, blood pressure, and waist
circumference (WC). For the obese and overweight subjects we will also obtain their growth
charts to attempt to correlate weight gain with psoriasis onset and progression. All data
will be compiled and then statistically analyzed.

Inclusion Criteria:

- Subjects must be between the ages of 5 and 17 years at the time of enrollment.

- Subjects of either sex.

- Subjects who have had psoriatic plaques for more than 6 months.

- Subjects and guardians of minors must sign the approved IRB consent form(s) prior to
initiation of the study protocol.

- Subjects enrolled as "non-inflammatory" normal controls will carry a common non-
systemic skin condition, such as acne, nevi, warts and molluscum as their main
diagnosis.

- Subjects enrolled as "inflammatory" normal controls will carry a diagnosis of
moderate to severe atopic dermatitis.

Exclusion Criteria:

- Subjects who are unable to give informed consent or assent.

- Subjects who have had psoriasis for less than 6 months.

- Subjects whose condition is deemed unsafe or incapable by the study investigator for
study participation.
We found this trial at
9
sites
Worcester, Massachusetts
?
mi
from
Worcester, MA
Click here to add this to my saved trials
9500 Gilman Dr
San Diego, California 92093
(858) 534-2230
University of California at San Diego UC San Diego is dedicated to the advancement of...
?
mi
from
San Diego, CA
Click here to add this to my saved trials
533 Parnassus Ave
San Francisco, California 94122
(415) 476-9000
University of California - San Francisco The leading university exclusively focused on health, UC San...
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
291 Campus Dr
Stanford, California 94305
(650) 725-3900
Stanford University School of Medicine Vast in both its physical scale and its impact on...
?
mi
from
Stanford, CA
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Dallas, Texas 75246
?
mi
from
Dallas, TX
Click here to add this to my saved trials
6621 Fannin St
Houston, Texas 77030
(832) 824-1000
Texas Children's Hospital Texas Children's Hospital, located in Houston, Texas, is a not-for-profit organization whose...
?
mi
from
Houston, TX
Click here to add this to my saved trials
St. Louis, Missouri 63117
?
mi
from
St. Louis, MO
Click here to add this to my saved trials